448 related articles for article (PubMed ID: 23206279)
1. Perspectives of stem cell therapy in Duchenne muscular dystrophy.
Meregalli M; Farini A; Belicchi M; Parolini D; Cassinelli L; Razini P; Sitzia C; Torrente Y
FEBS J; 2013 Sep; 280(17):4251-62. PubMed ID: 23206279
[TBL] [Abstract][Full Text] [Related]
2. [Cell therapy for Duchenne muscular dystrophy].
Zhou C; Zhang C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):659-61. PubMed ID: 17160947
[TBL] [Abstract][Full Text] [Related]
3. Cell based therapy for Duchenne muscular dystrophy.
Farini A; Razini P; Erratico S; Torrente Y; Meregalli M
J Cell Physiol; 2009 Dec; 221(3):526-34. PubMed ID: 19688776
[TBL] [Abstract][Full Text] [Related]
4. Stem cell therapies to treat muscular dystrophy: progress to date.
Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
[TBL] [Abstract][Full Text] [Related]
5. [Duchenne muscular dystrophy: perspectives of treatment].
Palmieri B; Sblendorio V
Recenti Prog Med; 2006 Sep; 97(9):448-58. PubMed ID: 17017294
[TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion.
Gonçalves MA; de Vries AA; Holkers M; van de Watering MJ; van der Velde I; van Nierop GP; Valerio D; Knaän-Shanzer S
Hum Mol Genet; 2006 Jan; 15(2):213-21. PubMed ID: 16321987
[TBL] [Abstract][Full Text] [Related]
7. Human Skeletal Muscle Cells Derived from the Orbicularis Oculi Have Regenerative Capacity for Duchenne Muscular Dystrophy.
Yamanaka Y; Takenaka N; Sakurai H; Ueno M; Kinoshita S; Sotozono C; Sato T
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31337111
[TBL] [Abstract][Full Text] [Related]
8. Muscle-derived stem cells: potential for muscle regeneration.
Huard J; Cao B; Qu-Petersen Z
Birth Defects Res C Embryo Today; 2003 Aug; 69(3):230-7. PubMed ID: 14671776
[TBL] [Abstract][Full Text] [Related]
9. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
[TBL] [Abstract][Full Text] [Related]
11. [Advance in therapy for Duchenne/Becker muscular dystrophy].
Xu TT; Lan D
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Mar; 17(3):294-8. PubMed ID: 25815505
[TBL] [Abstract][Full Text] [Related]
12. Myogenic stem cells: regeneration and cell therapy in human skeletal muscle.
Negroni E; Butler-Browne GS; Mouly V
Pathol Biol (Paris); 2006 Mar; 54(2):100-8. PubMed ID: 16246502
[TBL] [Abstract][Full Text] [Related]
13. Development of therapy for Duchenne muscular dystrophy.
Zhang S; Xie H; Zhou G; Yang Z
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):194-203. PubMed ID: 17357471
[TBL] [Abstract][Full Text] [Related]
14. Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs.
Rouger K; Larcher T; Dubreil L; Deschamps JY; Le Guiner C; Jouvion G; Delorme B; Lieubeau B; Carlus M; Fornasari B; Theret M; Orlando P; Ledevin M; Zuber C; Leroux I; Deleau S; Guigand L; Testault I; Le Rumeur E; Fiszman M; Chérel Y
Am J Pathol; 2011 Nov; 179(5):2501-18. PubMed ID: 21924229
[TBL] [Abstract][Full Text] [Related]
15. Cell therapies for muscular dystrophy.
Blau HM
N Engl J Med; 2008 Sep; 359(13):1403-5. PubMed ID: 18815403
[No Abstract] [Full Text] [Related]
16. Repair or replace? Exploiting novel gene and cell therapy strategies for muscular dystrophies.
Benedetti S; Hoshiya H; Tedesco FS
FEBS J; 2013 Sep; 280(17):4263-80. PubMed ID: 23387802
[TBL] [Abstract][Full Text] [Related]
17. The allure of stem cell therapy for muscular dystrophy.
Grounds MD; Davies KE
Neuromuscul Disord; 2007 Mar; 17(3):206-8. PubMed ID: 17306535
[TBL] [Abstract][Full Text] [Related]
18. Exon-skipping therapy for Duchenne muscular dystrophy.
Nakamura A; Takeda S
Neuropathology; 2009 Aug; 29(4):494-501. PubMed ID: 19486303
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update.
Sun C; Shen L; Zhang Z; Xie X
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32717791
[TBL] [Abstract][Full Text] [Related]
20. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
Li S; Kimura E; Fall BM; Reyes M; Angello JC; Welikson R; Hauschka SD; Chamberlain JS
Gene Ther; 2005 Jul; 12(14):1099-108. PubMed ID: 15759015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
